Literature DB >> 1436270

Glyburide-induced cholestatic hepatitis and liver failure. Case-report and review of the literature.

J P van Basten1, B van Hoek, R Zeijen, R Stockbrügger.   

Abstract

As sulphonylurea derivatives are used ubiquitously, the possibility that they may cause liver disease deserves attention. In contrast to the known pattern of reversible parenchymal liver disease due to sulphonylurea derivatives, we describe a fatal case of glyburide-induced cholestatic hepatitis with liver failure.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1436270

Source DB:  PubMed          Journal:  Neth J Med        ISSN： 0300-2977            Impact factor:   1.422


  4 in total

Review 1.  Drug-induced liver injury: is it somehow foreseeable?

Authors:  Giovanni Tarantino; Matteo Nicola Dario Di Minno; Domenico Capone
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

2.  Liver safety in patients with type 2 diabetes treated with pioglitazone: results from a 3-year, randomized, comparator-controlled study in the US.

Authors:  Keith G Tolman; James W Freston; Stuart Kupfer; Alfonso Perez
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 3.  Granulomatous hepatitis associated with glyburide.

Authors:  D Saw; E Pitman; M Maung; P Savasatit; D Wasserman; C K Yeung
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

4.  Mechanistic Modeling Reveals the Critical Knowledge Gaps in Bile Acid-Mediated DILI.

Authors:  J L Woodhead; K Yang; K L R Brouwer; S Q Siler; S H Stahl; J L Ambroso; D Baker; P B Watkins; B A Howell
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-07-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.